Revance Therapeutics CEO Dan Browne has stepped down as company head due to "misjudgment in handling an employee matter," the California-based biotech announced Monday.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,